Based on the clinicopathological characteristics of the tumor stage, we discovered that NEK2 mRNA expression tended to be significantly higher in more advanced tumor stages, whereas NEK6/8/11 mRNA expressions were only found in tumor stages 1, 2, and 3. This evidence concerns the gene NEK6 and neoplasm.